Ten potential drug targets for allergic diseases were identified, comprising TNFAIP3, LAYN, TLR1, IL1R1, IL1RL1, IL6R, KYNU, ITPKA, LRP11 and ERBB3. This evidence concerns the gene TLR1 and allergic disease.